BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19132106)

  • 1. Production of nitric oxide and expression of inducible nitric oxide synthase in ovarian cystic tumors.
    Nomelini RS; de Abreu Ribeiro LC; Tavares-Murta BM; Adad SJ; Murta EF
    Mediators Inflamm; 2008; 2008():186584. PubMed ID: 19132106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
    Saied EM; El-Etreby NM
    Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are NHE1 and inducible nitric oxide synthase involved in human ovarian cancer?
    Sanhueza C; Araos J; Naranjo L; Barros E; Toledo L; Subiabre M; Toledo F; Gutiérrez J; Chiarello DI; Pardo F; Leiva A; Sobrevia L
    Pharmacol Res; 2016 Mar; 105():183-5. PubMed ID: 26821117
    [No Abstract]   [Full Text] [Related]  

  • 4. iNOS-derived nitric oxide promotes glycolysis by inducing pyruvate kinase M2 nuclear translocation in ovarian cancer.
    Li L; Zhu L; Hao B; Gao W; Wang Q; Li K; Wang M; Huang M; Liu Z; Yang Q; Li X; Zhong Z; Huang W; Xiao G; Xu Y; Yao K; Liu Q
    Oncotarget; 2017 May; 8(20):33047-33063. PubMed ID: 28380434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of 17beta-estradiol and progesterone on ovarian carcinoma cell proliferation: a potential role for inducible nitric oxide synthase.
    Keith Bechtel M; Bonavida B
    Gynecol Oncol; 2001 Jul; 82(1):127-38. PubMed ID: 11426974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
    Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
    Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of nitric oxide in uterine junctional zone of patients with adenomyosis].
    Liu JJ; Duan H; Wang S
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):504-7. PubMed ID: 24284220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different patterns of inducible nitric oxide synthase gene expression in ovarian carcinoma cell lines.
    Rieder J; Marth C; Totzke G; Smolny M; Seibel M; Hoffmann G
    Anticancer Res; 2000; 20(5A):3251-8. PubMed ID: 11062750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hindlimb ischemia/reperfusion-induced remote injury to the small intestine: role of inducible nitric-oxide synthase-derived nitric oxide.
    Katada K; Bihari A; Badhwar A; Yoshida N; Yoshikawa T; Potter RF; Cepinskas G
    J Pharmacol Exp Ther; 2009 Jun; 329(3):919-27. PubMed ID: 19270191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer.
    Cianchi F; Cortesini C; Fantappiè O; Messerini L; Sardi I; Lasagna N; Perna F; Fabbroni V; Di Felice A; Perigli G; Mazzanti R; Masini E
    Clin Cancer Res; 2004 Apr; 10(8):2694-704. PubMed ID: 15102673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the predictive response of a simple and sensitive blood-based biomarker between estrogen-negative solid tumors.
    Mohan S; Patel S; Barlow D; Rojas AC
    Adv Med Sci; 2020 Sep; 65(2):424-428. PubMed ID: 32919119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The homeoprotein DLX4 controls inducible nitric oxide synthase-mediated angiogenesis in ovarian cancer.
    Trinh B; Ko SY; Haria D; Barengo N; Naora H
    Mol Cancer; 2015 Apr; 14():97. PubMed ID: 25924901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High concentrations of inhibin A and inhibin B in ovarian serous cystadenoma: relationship with oestradiol and nitric oxide metabolites.
    Reis FM; Faletti A; Luisi S; Bifulco G; Cauci S; Quadrifoglio F; Dor J; Petraglia F
    Mol Hum Reprod; 2000 Dec; 6(12):1079-83. PubMed ID: 11101690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fetal hypothyroidism on tolerance to ischemia-reperfusion injury in aged male rats: Role of nitric oxide.
    Jeddi S; Zaman J; Ghasemi A
    Nitric Oxide; 2016 May; 55-56():82-90. PubMed ID: 27074518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters?
    Ozel E; Peştereli HE; Simşek T; Erdoğan G; Karaveli FS
    Int J Gynecol Cancer; 2006; 16(2):549-55. PubMed ID: 16681724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Intracystic Cytokines and Nitric Oxide in Ovarian Neoplasms.
    Martins-Filho A; Jammal MP; Micheli DC; Tavares-Murta BM; Etchebehere RM; Murta EFC; Nomelini RS
    Scand J Immunol; 2017 Dec; 86(6):462-470. PubMed ID: 28960399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin dose dependently inhibits the interleukin-1 beta-stimulated increase in inducible nitric oxide synthase, nitric oxide, and prostaglandin E(2) production in rat ovarian dispersates cultured in vitro.
    Carnovale DE; Fukuda A; Underhill DC; Laffan JJ; Breuel KF
    Fertil Steril; 2001 Apr; 75(4):778-84. PubMed ID: 11287034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential Role of iNOS in Ovarian Cancer Progression and Chemoresistance.
    Kielbik M; Szulc-Kielbik I; Klink M
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant enzymes suppress nitric oxide production through the inhibition of NF-kappa B activation: role of H(2)O(2) and nitric oxide in inducible nitric oxide synthase expression in macrophages.
    Han YJ; Kwon YG; Chung HT; Lee SK; Simmons RL; Billiar TR; Kim YM
    Nitric Oxide; 2001; 5(5):504-13. PubMed ID: 11587565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide and inflammatory bowel disease: evidence for local intestinal production in children with active colonic disease.
    Levine JJ; Pettei MJ; Valderrama E; Gold DM; Kessler BH; Trachtman H
    J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):34-8. PubMed ID: 9443117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.